James Brady
Directeur/Membre du Conseil chez VERONA PHARMA PLC
Fortune : - $ au 30/06/2024
Profil
James Brady is an Independent Non-Executive Director at Verona Pharma Plc and a Director at Panavance Therapeutics, Inc. He was previously the Chief Financial Officer at MedImmune Ltd.
from 2013 to 2018.
He holds an MBA from Drexel University and an undergraduate degree from St. Joseph University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VERONA PHARMA PLC
-.--% | 29/04/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de James Brady
| Sociétés | Poste | Début |
|---|---|---|
| VERONA PHARMA PLC | Directeur/Membre du Conseil | 14/03/2022 |
| Panavance Therapeutics, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de James Brady
| Sociétés | Poste | Fin |
|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Directeur Financier/CFO | 01/01/2018 |
Formation de James Brady
| Drexel University | Masters Business Admin |
| St. Joseph University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VERONA PHARMA PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Panavance Therapeutics, Inc. |
